drugset / Trial / NCT01024517
GLPG0259 Solid Formulation Bioavailability and Food Effect
RandomizedCrossoverOpen-label
Summary
The purpose of the study is to compare the pharmacokinetics of GLPG0259 as a solid dosage formulation (with and without food)and an oral solution, and to assess its safety and tolerability.
Timeline
- Start
- 2009-11
- Primary completion
- 2009-12
- Completion
- 2010-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GLPG0259 | Small molecule | 50 mg | Oral |
Indications
No indication recorded.